ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, B.
Right arrow Articles by Netzloff, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, B.
Right arrow Articles by Netzloff, M.
Annals of Clinical and Laboratory Science, Vol 13, Issue 4, 315-320
Copyright © 1983 by Association of Clinical Scientists


Articles

Primary testicular abnormalities causing precocious puberty Leydig cell tumor, Leydig cell hyperplasia, and adrenal rest tumor

BE Wilson and ML Netzloff

The child with testicular enlargement in the absence of gonadotrophin stimulation presents a difficult diagnostic dilemma. Leydig cell tumors, Leydig cell hyperplasia, and tumors of adrenal rest tissue are the primary etiologic considerations. Because of considerable overlap in clinical presentation, careful biochemical and histologic evaluations are necessary to make the diagnosis. These should include serum levels of testosterone, dehydroepiandosterone, androstenedione, 17-hydroxyprogesterone, and 11-desoxycortisol, as well as urinary levels of 17-ketosteroids. If diagnostic changes in the biochemical profile are not present, then testicular biopsy is indicated. Encapsulation, presence or absence of the crystalloids of Reinke, degree of seminiferous tubule maturation, and the site of any abnormal tissue are important observations in the examination of the tissue specimen. Once the diagnosis has been established, then appropriate and specific medical or surgical therapy can be instituted. With appropriate treatment, the long-term prognosis in each condition is good.


This article has been cited by other articles:


Home page
NEJMHome page
G. Liu, L. Duranteau, J.-C. Carel, J. Monroe, D. A. Doyle, and A. Shenker
Leydig-Cell Tumors Caused by an Activating Mutation of the Gene Encoding the Luteinizing Hormone Receptor
N. Engl. J. Med., December 2, 1999; 341(23): 1731 - 1736.
[Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
D. Prentice and A. Meikle
A review of drug-induced Leydig cell hyperplasia and neoplasia in the rat and some comparisons with man
Human and Experimental Toxicology, July 1, 1995; 14(7): 562 - 572.
[Abstract] [PDF]


Home page
CLIN PEDIATRHome page
E. Kaufman, F. Akiya, E. Foucar, F. Grambort, and K. C. Cartwright
Viralization Due to Leydig Cell Tumor Diagnosis by Magnetic Resonance Imaging: Case Management Report
Clinical Pediatrics, July 1, 1990; 29(7): 414 - 417.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the Association of Clinical Scientists.